PHASE 3 TRIAL OF BRENTUXIMAB VEDOTIN AND CHP VERSUS CHOP IN THE FRONTLINE TREATMENT OF PATIENTS (PTS) WITH CD30+MATURE T-CELL LYMPHOMAS (MTCL)

ISSN
1569-8041
0923-7534
Date Issued
2014
Author(s)
Illidge, Tim
Pro, Barbara
Larsen, Emily K.
Kennedy, Dana A.
O'Connor, O.
DOI
10.1093/annonc/mdu339.41